Mesothelin expression in gastrointestinal carcinomas

Mesothelin expression in gastrointestinal carcinomas - Mesothelin expression in gastrointestinal carcinomas

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017317

Enrollment

100

Registered

2015-04-30

Start date

2011-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal carcinomas

Interventions

Mesothelin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: curative resection

Exclusion criteria

Exclusion criteria: multiple metastasis

Design outcomes

Primary

Measure	Time frame
High-level expression of mesothelin was correlated with poor patient outcome.	—

Countries

Japan

Contacts

Public ContactKawamata Futoshi

Hokkaido University School of Medicine Gastroenterological Surgery I

k-futoshi@cotton.ocn.ne.jp011-706-5927

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026